EARNINGS PER COMMON SHARE - Schedule of Anti-Dilutive Common Stock Excluded from Computation of Diluted Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially issuable shares (in shares)	10,947	12,975
$0.599% senior subordinated convertible notes due in August 2024 (the 2024 Notes) | Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares issued if converted (in shares)	4,000
1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes) | Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential shares issued if converted (in shares)	4,400
Common stock issuable under the Company's equity incentive plans
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially issuable shares (in shares)	10,947	8,610
Common stock issuable under the Company’s convertible debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total number of potentially issuable shares (in shares)	0	4,365